What question did this study set out to answer?

To explore the challenges and outcomes associated with glioblastoma multiforme in resource-limited settings.

Glioblastoma multiforme: the aggressive void in cancer care

View Full Paper

Ask AI

Bookmark

Authors

This Cohort Study Reports Survival Outcomes in Glioblastoma Patients, Highlighting Systemic Barriers in Cancer Care.

To explore the challenges and outcomes associated with glioblastoma multiforme in resource-limited settings.
Cohort study assessing survival outcomes in GBM patients from low- and middle-income countries.
Evaluation of treatment approaches including surgery, radiotherapy, and chemotherapy.
Examination of barriers to effective cancer care and access to treatments.
Only 33% of GBM patients were documented as alive at follow-up, indicating poor long-term survival.
Median survival increased from 12.1 months for radiotherapy alone to 14.6 months with temozolomide, indicating treatment impact.
47.3% achieved gross total resection, yet significant follow-up loss (47%) suggests gaps in care.

Javed et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark